Stifel Reiterates Buy Rating on Vital Farms (VITL)

Stifel analyst Matthew Smith reiterated a Buy rating and $44.00 price target on Vital Farms (NASDAQ: VITL).

The analyst commented, “We traveled with Vital Farms management last week following the egg journey from farm to retail shelf and come away with a greater appreciation of Vital’s unique supply chain and the steps the company is making in 2025 to improve capacity and efficiency. 2025 is a tale of two halves with growth accelerating in the second half, benefiting from improved supply and normalized margin comparisons.”

Also, “We continue to estimate 23% revenue growth in 2025, primarily supported by egg volume growth, with only mid-teen growth required in 2026-2027 to reach the company’s >$1 billion revenue target. We view shares as undervalued at just 10x 2026 EV/EBITDA and see attractive upside for shares as growth accelerates through 2025.”

For an analyst ratings summary and ratings history on Vital Farms click here. For more ratings news on Vital Farms click here.

Shares of Vital Farms closed at $30.94 yesterday.

You May Also Be Interested In

• Anthropic Said In Talks To Buy Ai Startup Decart For $6 Billion - Bloomberg
• Logistic Properties of the Americas (LPA) Reports Q2 results
• H.B. Fuller receives $1.1B-$1.2B bid for building adhesives unit